San Jose, CA, United States of America

Theo Teofanov Nikiforov

This inventor holds 30 USPTO granted patents and 3 EPO patents, primarily in Microfluidic Systems. Top assignees: Caliper Technologies Corporation, Caliper Life Sciences, Inc., Janssen Pharmaceutica Nv. Active years: 1999-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theo Teofanov Nikiforov. Retrieved from https://idiyas.com/inventor/theo-teofanov-nikiforov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 73.3

 

Average Co-Inventor Count = 1.8

ph-index = 15

Forward Citations = 2,924(Granted Patents)


Location History:

  • Campbell, CA (US) (1999 - 2001)
  • San Jose, CA (US) (2001 - 2018)

Company Filing History:


Years Active: 1999-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Microparticle Manipulation
11-Beta Hydroxysteroid Dehydrogenase Inhibitors
Nucleic Acid Sequencing
Fluorescent Polarization Assays
Kinase Assays
Pressure-Based Mobility Shift Assays
Background Signal Reduction
Intracellular Binding Reactions
Fluid Transport Enhancement
Assay Methods
Primer Extension
Multivalent Metal Ions
30 patents (USPTO):Explore Patents

Title: Innovator Profile: Theo Teofanov Nikiforov

Introduction

Theo Teofanov Nikiforov is a renowned innovator based in San Jose, California, with an impressive portfolio of 30 patents. His contributions primarily focus on advancing microfluidic systems and related chemical processes, which have significant implications in various scientific fields.

Latest Patents

Among his latest inventions is a groundbreaking microfluidic device designed for the manipulation of microparticles. This device features an array of transportable particle sets that facilitate chemical reactions within a microfluidic environment. The architecture includes a main channel and intersecting side channels, allowing for a multitude of interactions that enable the transport of reagents into contact with selected array members, thereby expanding the potential for complex chemical reactions. Additionally, Theo has developed pyrrolidin-2-one and piperidin-2-one derivatives that act as 11-beta hydroxysteroid dehydrogenase inhibitors, showcasing his expertise in pharmaceutical chemistry.

Career Highlights

Throughout his career, Theo has made significant strides in the biotechnology industry. He has worked with notable companies, including Caliper Technologies Corporation and Caliper Life Sciences, Inc., where his expertise has led to the development of cutting-edge technologies in microfluidics and drug delivery systems.

Collaborations

Theo has collaborated with outstanding professionals in his field, including J Wallace Parce and Tammy Burd Mehta. These partnerships have enabled him to enhance his research and drive innovation in the projects he undertakes.

Conclusion

Theo Teofanov Nikiforov continues to be a pivotal figure in the realm of innovative inventions and patent applications. His work not only demonstrates his commitment to advancing scientific knowledge but also emphasizes the importance of collaboration and creativity in achieving remarkable technological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…